cash flow reconciliationreview2017-12-31
Operating, investing and financing flows differ from the reported change in cash by 164000000, beyond tolerance 15280000.00.
Revenue
$11.17B
Fiscal year ended 2025-12-31Operating income
-$1.58B
Fiscal year ended 2025-12-31Free cash flow
-$530.00M
Fiscal year ended 2025-12-31WESTLAKE CORP (WLK) reported revenue of $11.17B and net income of -$1.51B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from WESTLAKE CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Organic Chemicals.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.17B | $12.14B | $12.55B | $15.79B | $11.78B | $7.50B | $8.12B | $8.64B | $8.04B | $5.08B |
| Cost of revenue | $10.36B | $10.18B | $10.33B | $11.72B | $8.28B | $6.48B | $6.86B | $6.65B | $6.28B | $4.09B |
| Gross profit | $813.00M | $1.96B | $2.22B | $4.07B | $3.50B | $1.02B | $1.26B | $1.99B | $1.76B | $983.00M |
| Operating income | -$1.58B | $875.00M | $729.00M | $3.05B | $2.80B | $429.00M | $656.00M | $1.41B | $1.22B | $583.00M |
| Net income | -$1.51B | $602.00M | $479.00M | $2.25B | $2.02B | $330.00M | $421.00M | $996.00M | $1.30B | $399.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 128.26M | shares 129.21M | shares 128.60M | shares 128.85M | shares 128.70M | shares 128.09M | shares 128.76M | shares 129.99M | shares 129.54M | shares 129.97M |
| Pretax income | -$1.60B | $938.00M | $700.00M | $2.95B | $2.68B | $331.00M | $570.00M | $1.33B | $1.08B | $558.00M |
| Income tax expense | -$126.00M | $291.00M | $178.00M | $649.00M | $607.00M | -$42.00M | $108.00M | $300.00M | -$258.00M | $138.00M |
| Diluted EPS | $-11.70 | $4.64 | $3.70 | $17.34 | $15.58 | $2.56 | $3.25 | $7.62 | $10.00 | $3.06 |
| Selling, general & administrative | $900.00M | $874.00M | $865.00M | $835.00M | $551.00M | $449.00M | $458.00M | $445.00M | $399.00M | $258.00M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.72B | $2.92B | $3.30B | $2.23B | $1.91B | $1.31B | $728.00M | $753.00M | $1.53B | $459.00M |
| Total assets | $19.96B | $20.75B | $21.04B | $20.55B | $18.46B | $13.84B | $13.26B | $11.60B | $12.08B | $10.89B |
| Current assets | $6.22B | $6.21B | $6.61B | $5.97B | $5.26B | $3.48B | $2.74B | $2.84B | $3.46B | $2.41B |
| Total liabilities | $10.67B | $9.71B | $10.27B | $10.08B | $9.93B | $7.26B | $6.86B | $5.53B | $6.71B | $7.00B |
| Current liabilities | $2.77B | $2.22B | $2.79B | $2.30B | $2.34B | $1.36B | $1.24B | $1.18B | $1.97B | $1.18B |
| Total equity incl. NCI | $9.30B | $11.04B | $10.76B | $10.46B | $8.53B | $6.58B | $6.40B | $6.08B | $5.37B | $3.89B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.65B | $1.70B | $1.62B | $1.87B | $1.41B | $918.00M | $936.00M | $1.01B | $900.00M | $801.00M |
| Accounts receivable | $1.23B | $1.32B | $1.39B | $1.65B | $1.74B | $1.08B | $938.00M | $952.00M | $961.00M | $810.00M |
| Goodwill | $1.31B | $2.03B | $2.04B | $2.16B | $2.02B | $1.08B | $1.07B | $1.00B | $1.01B | $947.00M |
| Long-term debt | $5.09B | $4.56B | $4.61B | $4.88B | $4.91B | $3.57B | $3.44B | $2.67B | $3.13B | $3.68B |
| Accounts payable | $783.00M | $851.00M | $877.00M | $889.00M | $879.00M | $536.00M | $473.00M | $507.00M | $600.00M | $496.00M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $465.00M | $1.31B | $2.34B | $3.40B | $2.39B | $1.30B | $1.30B | $1.41B | $1.53B | $867.00M |
| Capital expenditures | $995.00M | $1.01B | $1.03B | $1.11B | $658.00M | $525.00M | $787.00M | $702.00M | $577.00M | $629.00M |
| Investing cash flow | -$1.22B | -$1.00B | -$1.04B | -$2.48B | -$3.21B | -$509.00M | -$1.95B | -$754.00M | -$652.00M | -$2.56B |
| Financing cash flow | $530.00M | -$650.00M | -$245.00M | -$587.00M | $1.44B | -$216.00M | $630.00M | -$1.43B | $6.00M | $1.69B |
| Net change in cash | -$195.00M | -$384.00M | $1.07B | $305.00M | $604.00M | $587.00M | -$25.00M | -$779.00M | $1.07B | -$204.00M |
| Stock-based compensation | $41.00M | $41.00M | $43.00M | $36.00M | $31.00M | $29.00M | $25.00M | $22.00M | $23.00M | $14.00M |
| Common dividends paid | $272.00M | $264.00M | $221.00M | $169.00M | $145.00M | $137.00M | $132.00M | $120.00M | $103.00M | $97.00M |
| Common share repurchases | $63.00M | $60.00M | $23.00M | $101.00M | $30.00M | $54.00M | $30.00M | $106.00M | $0 | $67.00M |
| Depreciation & amortization | $1.18B | $1.11B | $1.10B | $1.06B | $840.00M | $773.00M | $713.00M | $641.00M | $601.00M | $378.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$530.00M | $306.00M | $1.30B | $2.29B | $1.74B | $772.00M | $514.00M | $707.00M | $951.00M | $238.00M |
| Gross margin | 7.3% | 16.1% | 17.7% | 25.8% | 29.7% | 13.6% | 15.5% | 23.0% | 21.9% | 19.4% |
| Operating margin | -14.1% | 7.2% | 5.8% | 19.3% | 23.8% | 5.7% | 8.1% | 16.3% | 15.2% | 11.5% |
| FCF margin | -4.7% | 2.5% | 10.4% | 14.5% | 14.7% | 10.3% | 6.3% | 8.2% | 11.8% | 4.7% |
| SBC / revenue | 0.4% | 0.3% | 0.3% | 0.2% | 0.3% | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% |
| Current ratio | 2.24x | 2.80x | 2.37x | 2.60x | 2.25x | 2.56x | 2.21x | 2.40x | 1.76x | 2.04x |
| Revenue YoY growth | -8.0% | -3.2% | -20.6% | 34.1% | 57.0% | -7.6% | -6.0% | 7.4% | 58.4% | Unavailable |
| Net margin | -13.5% | 5.0% | 3.8% | 14.2% | 17.1% | 4.4% | 5.2% | 11.5% | 16.2% | 7.9% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 8.9% | 8.3% | 8.2% | 7.0% | 5.6% | 7.0% | 9.7% | 8.1% | 7.2% | 12.4% |
| Long-term debt / equity | 0.55x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | 31.0% | 25.4% | 22.0% | 22.7% | -12.7% | 18.9% | 22.5% | -23.9% | 24.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WLK in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-02View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2016-12-31
Operating, investing and financing flows differ from the reported change in cash by 187000000, beyond tolerance 25630000.00.